Cargando…

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy

BACKGROUND: Diabetic retinopathy (DR) is a serious complication of longstanding type 2 diabetes mellitus (T2DM), a leading cause of blindness and visual disability in the world. The aim of this study is to compare the activity of tissue plasminogen activator (tPA) and plasminogen activator inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jasmiad, Nurbadriah binti, Abd Ghani, Rohana binti, Agarwal, Renu, Ismail, Zaliha binti, Mohd Abdullah, Azlindarita Aisyah, Idorus, Mohd Yusri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441077/ https://www.ncbi.nlm.nih.gov/pubmed/36057550 http://dx.doi.org/10.1186/s12886-022-02550-4

Ejemplares similares

PSUN171 CORRELATIONS BETWEEN SERUM AND TEAR PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) AND TISSUE PLASMINOGEN ACTIVATOR (tPA) IN PATIENTS WITH DIABETIC RETINOPATHY
por: Jasmiad, Nurbadriah, et al.
Publicado: (2022)

Plasminogen activator activity in tears of pregnant women
por: Csutak, Adrienne, et al.
Publicado: (2017)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

THE ACTIVATION OF PLASMINOGEN BY CHLOROFORM
por: Christensen, L. R.
Publicado: (1946)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
por: Gupta, Kamlesh K., et al.
Publicado: (2017)

Plasminogen and Plasminogen Activators Protect against Renal Injury in Crescentic Glomerulonephritis
por: Kitching, A. Richard, et al.
Publicado: (1997)

Effect of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms on Susceptibility to Type 2 Diabetes in Malaysian Subjects
por: Al-Hamodi, Zaid, et al.
Publicado: (2012)

Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
por: Al-Hamodi, Zaid, et al.
Publicado: (2011)

Zinc-Triggered Induction of Tissue Plasminogen Activator and Plasminogen in Endothelial Cells and Pericytes
por: Cho, Mun-Kyung, et al.
Publicado: (2013)

Yersinia pestis Plasminogen Activator
por: Sebbane, Florent, et al.
Publicado: (2020)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
por: Seok, Su-Jin, et al.
Publicado: (2011)

Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1
por: Gong, Lihu, et al.
Publicado: (2016)

Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression
por: Tsai, Shih-Jen
Publicado: (2017)

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
por: Zuo, Yu, et al.
Publicado: (2021)

Evaluation of Serum Fibrinogen, Plasminogen, α2-Anti-Plasmin, and Plasminogen Activator Inhibitor Levels (PAI) and Their Correlation with Presence of Retinopathy in Patients with Type 1 DM
por: Polat, Sefika Burcak, et al.
Publicado: (2014)

Plasminogen
por: Kline, Daniel L.
Publicado: (1954)

CNDP1, NOS3, and MnSOD Polymorphisms as Risk Factors for Diabetic Nephropathy among Type 2 Diabetic Patients in Malaysia
por: Yahya, Mohd Jokha, et al.
Publicado: (2019)

Association of CCL2, CCR5, ELMO1, and IL8 Polymorphism with Diabetic Nephropathy in Malaysian Type 2 Diabetic Patients
por: Yahya, Mohd Jokha, et al.
Publicado: (2019)

Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency
por: Saes, Joline L., et al.
Publicado: (2019)

Premature delivery impacts the concentration of plasminogen activators and a plasminogen activator inhibitor and the plasmin activity in human milk
por: Demers-Mathieu, Veronique, et al.
Publicado: (2022)

The Plasminogen–Activator Plasmin System in Physiological and Pathophysiological Angiogenesis
por: Ismail, Asmaa Anwar, et al.
Publicado: (2021)

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.
por: Knoop, A., et al.
Publicado: (1998)

Relationship between tissue plasminogen activator, plasminogen activator inhibitor and CT image in chronic subdural hematoma.
por: Lim, D. J., et al.
Publicado: (1995)

SECRETION OF PLASMINOGEN ACTIVATOR BY STIMULATED MACROPHAGES
por: Unkeless, Jay C., et al.
Publicado: (1974)

Induction of plasminogen activator synthesis by antibodies
Publicado: (1981)

Plasminogen Activators in Neurovascular and Neurodegenerative Disorders
por: Yepes, Manuel, et al.
Publicado: (2021)

Ligand binding modulates the structural dynamics and activity of urokinase-type plasminogen activator: A possible mechanism of plasminogen activation
por: Kromann-Hansen, Tobias, et al.
Publicado: (2018)

Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2
Publicado: (1988)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1 Contribute to Sonic Hedgehog-Induced In Vitro Cerebral Angiogenesis
por: Teng, Hua, et al.
Publicado: (2012)

The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
por: Pieters, Marlien, et al.
Publicado: (2017)

Is the Urokinase Plasminogen Activator/Plasminogen Activator Inhibitor-1 Ratio a Marker of Sonographic Septations in Pleural Infection?
por: Yasuma, Taro, et al.
Publicado: (2022)

Measuring and explaining multi-directional inefficiency in the Malaysian dairy industry
por: Mohd Suhaimi, Nurul Aisyah Binti, et al.
Publicado: (2017)

Plasminogen Receptors
por: Miles, Lindsey A., et al.
Publicado: (2012)

Gut microbiota in pregnant Malaysian women: a comparison between trimesters, body mass index and gestational diabetes status
por: Abdullah, Bahiyah, et al.
Publicado: (2022)

Tissue plasminogen activator and plasminogen activator inhibitor type 1 gene polymorphism in patients with gastric ulcer complicated with bleeding.
por: Kim, Hong-Soo, et al.
Publicado: (2003)

Evaluation of Prognostic Values of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Crimean-Congo Hemorrhagic Fever Patients
por: Gurbuz, Yunus, et al.
Publicado: (2015)

Retraction: The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
Publicado: (2018)

Vitamin D Deficiency is Associated With Increased Plasminogen Activator Inhibitor 1/Plasminogen Activator Inhibitor 2 Ratio in Pregnancy
por: Andersen, Matilde Kanstrup, et al.
Publicado: (2023)

From Plasminogen to Plasmin: Role of Plasminogen Receptors in Human Cancer
por: Didiasova, Miroslava, et al.
Publicado: (2014)

Evaluation of cardiovascular disease in patients with systemic arterial hypertension in relation to age and sex: a retrospective study in a south Indian population
por: Padur, Ashwini Aithal, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_43ojpig6mou1sag4pu0qipbsji